The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Belite Bio, Inc(NASDAQ:BLTE)


Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.
Website: https://belitebio.com/
Founded: 2016
IPO Price: $6 (Apr 29, 2022)
CEO / Founder: Dr. Tom Lin
Sector: Technology
Industry: General
Share this website to your friends
Belite Bio Op Cashflow Per Share ttm
Belite Bio Free Cashflow Per Share ttm
Belite Bio Cash Per Share ttm
Belite Bio (GAAP) P/E ratio ttm
Belite Bio P/B ratio ttm
No extra charts and metrics for this ticker.